157 related articles for article (PubMed ID: 8619784)
1. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
Baker RS; Flowers CW; Casey R; Fong DS; Wilson MR
Arch Ophthalmol; 1996 May; 114(5):632-3. PubMed ID: 8619784
[No Abstract] [Full Text] [Related]
2. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
[TBL] [Abstract][Full Text] [Related]
3. Moxifloxacin for bacterial keratitis.
Rosenberg J; Eisen L; Kim J
Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
[No Abstract] [Full Text] [Related]
4. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Panda A; Ahuja R; Sastry SS
Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
[TBL] [Abstract][Full Text] [Related]
6. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.
Khokhar S; Sindhu N; Mirdha BR
Infection; 2000; 28(3):149-52. PubMed ID: 10879638
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolones in the treatment of bacterial keratitis.
Bower KS; Kowalski RP; Gordon YJ
Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
[TBL] [Abstract][Full Text] [Related]
9. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
Bashir H; Dave A; Mathur U
Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400
[No Abstract] [Full Text] [Related]
10. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy versus fortified antibiotics for bacterial keratitis.
Rosenberg JB; Gritz DC
Cornea; 2011 Sep; 30(9):1066; author reply 1066-7. PubMed ID: 21775886
[No Abstract] [Full Text] [Related]
14. Fluoroquinolones in corneal ulcers.
Galvis V; Tello A; Guerra AR; Acuña MF; Villarreal D
Ophthalmology; 2013 Sep; 120(9):e61-2. PubMed ID: 24001539
[No Abstract] [Full Text] [Related]
15. Author reply: To PMID 23415776.
Sharma N; Goel M; Bansal S; Agarwal P; Titiyal J; Upadhyaya A; Vajpayee R
Ophthalmology; 2013 Sep; 120(9):e62. PubMed ID: 24001541
[No Abstract] [Full Text] [Related]
16. Pseudomonas keratitis after laser in situ keratomileusis.
Sharma N; Sinha R; Singhvi A; Tandon R
J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.
Gangopadhyay N; Daniell M; Weih L; Taylor HR
Br J Ophthalmol; 2000 Apr; 84(4):378-84. PubMed ID: 10729294
[TBL] [Abstract][Full Text] [Related]
18. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A.
Pollhammer M; Cursiefen C
J Cataract Refract Surg; 2009 Mar; 35(3):588-9. PubMed ID: 19251154
[TBL] [Abstract][Full Text] [Related]
19. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
Jhanji V; Sharma N; Satpathy G; Titiyal J
J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
